Corpus Intelligence IC Memo — OUACHITA COUNTY MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — OUACHITA COUNTY MEDICAL CENTER
Investment Committee Memorandum | AR | 82 beds | Grade C | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

OUACHITA COUNTY MEDICAL CENTER

CCN 040050 | OUACHITA, AR | 82 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

OUACHITA COUNTY MEDICAL CENTER is a 82-bed under-performing / distressed in OUACHITA, AR with $30.2M in net patient revenue and a -27.2% operating margin. The hospital serves a payer mix of 29.4% Medicare, 13.5% Medicaid, and 57.1% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -27.2% to -19.8% (+736bps).

Net Revenue HCRIS$30.2M
Current EBITDA COMPUTED$-8.2M
Operating Margin COMPUTED-27.2%
Occupancy HCRIS14.4%
Revenue / Bed COMPUTED$368K
Net-to-Gross HCRIS26.6%
Distress Probability ML59.5%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
34
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -27.2% places it below the state median. Among 34 size-comparable peers (41-164 beds), the median margin is 0.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (41-164), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
OUACHITA COUNTY MEDICAL CENTER (Target)AR82$30.2M-27.2%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%
ST. MARYS REGIONAL MEDICAL CENAR137$94.3M6.7%
SALINE MEMORIAL HOSPITALAR130$91.4M-8.0%
NORTH ARKANSAS REGIONAL MEDICAAR120$89.1M-13.9%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$633K+210bp18mo
Cost to Collect4.5%2.5%$603K+200bp12mo
Denial Rate Reduction12.0%6.5%$597K+198bp12mo
A/R Days Reduction5200.0%3800.0%$367K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$633K
Cost to Collect
$603K
Denial Rate Reduction
$597K
A/R Days Reduction
$367K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$-8.2M
+ RCM Uplift+$2.2M
Pro Forma EBITDA$-6.0M
Current Margin-27.2%
Pro Forma Margin-19.8%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.6M$-31.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.6M$-39.1M0.00x-100.0%
Bull Case9.0x11.0x$-11.3M$-35.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.3M$-42.5M0.00x-100.0%
Bear Case11.0x10.0x$-13.9M$-38.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.9M$-47.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 14.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 41-164 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-15.2% / P50=0.0% / P75=10.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.